Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00072
|
|||||
| Drug Name |
Lifitegrast
|
|||||
| Synonyms |
SAR-1118; SAR-1119; SHP606; SPD606; Xiidra
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Dry eye disease [ICD11: 9A79] | Approved | [1] | |||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C29H24Cl2N2O7S
|
|||||
| Canonical SMILES |
CS(=O)(=O)C1=CC=CC(=C1)CC(C(=O)O)NC(=O)C2=C(C=C3CN(CCC3=C2Cl)C(=O)C4=CC5=C(C=C4)C=CO5)Cl
|
|||||
| InChI |
InChI=1S/C29H24Cl2N2O7S/c1-41(38,39)20-4-2-3-16(11-20)12-23(29(36)37)32-27(34)25-22(30)13-19-15-33(9-7-21(19)26(25)31)28(35)18-6-5-17-8-10-40-24(17)14-18/h2-6,8,10-11,13-14,23H,7,9,12,15H2,1H3,(H,32,34)(H,36,37)/t23-/m0/s1
|
|||||
| InChIKey |
JFOZKMSJYSPYLN-QHCPKHFHSA-N
|
|||||
| CAS Number |
CAS 1025967-78-5
|
|||||
| Pharmaceutical Properties | Molecular Weight | 615.5 | Topological Polar Surface Area | 142 | ||
| Heavy Atom Count | 41 | Rotatable Bond Count | 7 | |||
| Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 7 | |||
| XLogP |
4.7
|
|||||
| PubChem CID | ||||||
| ChEBI ID |
ChEBI:133023
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | OATP1A2 | Transporter Info | Organic anion transporting polypeptide 1A2 | Substrate | [2] | |
| OATP2B1 | Transporter Info | Organic anion transporting polypeptide 2B1 | Substrate | [2] | ||
| References | ||||||
| 1 | Lifitegrast was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
| 2 | Clinical Pharmacology and Biopharmaceutics review(s) | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.